
BNTX vs MRNA
$BNTX vs $MRNA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
BNTX vs MRNA: the quick read
- ·MRNA is the larger company by market cap ($61.50B vs $24.13B).
- ·MRNA has been more active on our scanner (331 vs 61 alerts in 30 days).
- ·BNTX has the smaller float (109.8M vs 354.9M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Biological Products, (No Diagnostic Substances) vs BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)), so they answer to different catalysts and a move in one says little about the other.
- ·MRNA draws far more of our scanner's attention, 331 unusual-volume alerts in 30 days against 61, so it is the more actively traded of the two by some distance.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing BNTX and MRNA on TheDesperateTrader.
- Is BNTX or MRNA the better stock?
- "Better" depends on your goal, and these two are not alike. MRNA is the larger company by market cap ($61.50B vs $24.13B). MRNA has been more active on our scanner (331 vs 61 alerts in 30 days). BNTX has the smaller float (109.8M vs 354.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between BNTX and MRNA?
- The differences that matter: they are not in the same business - BNTX is biological products, (no diagnostic substances) and MRNA is biological products, (no diagnostic substances); they are similar in size ($24.13B vs $61.50B); they trade at very different share prices ($97.00 vs $153.87); BNTX sits at 39% of its 52-week range against 85% for MRNA; our scanner flagged BNTX 61 times in the last 30 days against 331 for MRNA. Everything above is measured from the latest completed session and SEC filings.
- Which of BNTX and MRNA is more active right now?
- Right now BNTX is at about 0.8x its normal volume and MRNA is at about 0.8x, so MRNA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading BNTX or MRNA? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore BNTX and MRNA comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.